Skip to content

Calcium D-Glucarate

Inhibits beta-glucuronidase, the gut enzyme that un-conjugates estrogen your liver already packaged for excretion — letting it be reabsorbed instead.

  • CategoryHormonal & Wellness
  • FormGlucaric acid salt
  • EvidenceClinical trials on file

Where to get Calcium D-Glucarate

iHerb
Glucaric acid salt

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesThe molecule in the capsule is not the molecule that does the work, and the conversion is the first thing this page has to establish. Calcium D-glucarate is the calcium salt of D-glucaric acid.
  • Who it is forEstrogen clearance protocols, usually alongside DIM.
  • What to watchWell tolerated; mild GI upset at higher doses.

How Calcium D-Glucarate works

Hydrolyzes to glucaro-1,4-lactone, which inhibits beta-glucuronidase — the bacterial enzyme in the gut that cleaves the glucuronide conjugate off compounds the liver has already prepared for excretion. Deconjugated estrogens and toxins are then reabsorbed rather than eliminated.

Read the rest of how it works

This targets the final step of clearance, which is the one most people skip.

Calcium D-Glucarate: serving, timing and spacing

Suggested serving
500–1,500 mg daily.
How often
Daily
When
With meals, split

Established intake rangeSet from human nutrition science — recommended intakes and tolerable upper limits built on decades of population data and deficiency work. This is a well-characterized range for a nutrient the body already uses, not a trial dose for a drug effect.

Good to know

Genuinely interesting mechanism, genuinely thin evidence. Grade it accordingly. Note the gut connection: this is one of several places where the microbiome directly affects hormone levels.

Research on Calcium D-Glucarate3 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • Human outcome data is essentially absent. The mechanism is well characterized; the clinical benefit is not demonstrated.

Correlative data

  • Same shape — glucaric acid occurs in oranges, apples and cruciferous vegetables, and the interest came from dietary association studies rather than from anything about the isolated calcium salt.

Theoretical / extrapolated benefits

  • If beta-glucuronidase activity is high — which correlates with certain gut microbiome patterns — more conjugated estrogen gets recycled. Inhibiting it should increase excretion. Elegant, and untested in outcomes.

Sources read for this page

  • Walaszek Z. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev 1997 · PMID 9101079
  • Hanausek M. Detoxifying cancer causing agents to prevent cancer. Integr Cancer Ther 2003 · PMID 15035900
  • Kowalczyk MC. Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. Int J Oncol 2013 · PMID 23835587
  • Ayyadurai VAS. Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach. Nutrients 2023 · PMID 36771439
  • Kemp DC, Fan PW, Stevens JC. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.. Drug Metab Dispos 2002 · PMID 12019197
  • Newman MS. The impact of 3,3'-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patch. Menopause 2025 · PMID 40298801

Calcium D-Glucarate, the deep readThe mechanism, cell to human, which form, how you would know

What Calcium D-Glucarate actually does

The molecule in the capsule is not the molecule that does the work, and the conversion is the first thing this page has to establish. Calcium D-glucarate is the calcium salt of D-glucaric acid. In the acid conditions of the stomach and the gut it is slowly converted to D-glucaro-1,4-lactone, and it is the lactone, not the acid, that inhibits beta-glucuronidase Walaszek 1997.

The enzyme it inhibits is the reverse of a detoxification step. Phase II conjugation attaches glucuronic acid to steroids, bilirubin, drugs and carcinogen metabolites, making them water-soluble and marking them for biliary or urinary export. Bacterial beta-glucuronidase in the colon cleaves that bond, liberating the aglycone so it can be reabsorbed. That loop is enterohepatic recirculation, and it is what a glucuronidase inhibitor is aimed at.

So the claimed mechanism is not detoxification. It is the prevention of re-toxification. Nothing about D-glucarate increases conjugation; the liver's UDP-glucuronosyltransferases are unaffected. What is proposed is that less deconjugation in the lumen means more of the conjugate leaves in the stool, and a systems-level analysis of D-glucaric acid frames it that way Ayyadurai 2023.

Which molecules that would matter for depends entirely on how much of their clearance runs through this loop. Estrogens are extensively glucuronidated and do undergo enterohepatic recycling, which is why the estrogen claim is the commonest one. Bilirubin, several drugs and some carcinogen metabolites use the same route. Compounds cleared by sulfation, oxidation or the kidney do not, and for those the mechanism cannot apply at all.

The interference is measurable in the opposite direction, which is the useful check. Intestinal glucuronidation is a quantitatively large contributor to presystemic clearance for drugs handled that way, as characterized directly for raloxifene Kemp 2002. A compound that changes the balance of conjugation and deconjugation in the gut is therefore a drug-interaction candidate before it is a supplement.

Cell, rodent, human — and where it stops

The chain is a rodent chemoprevention chain, and the human end of it consists of a marker nobody measures in a clinic.

In animals the effect is real and the endpoint is a tumor. D-glucarate salts reduce chemically induced tumorigenesis in rodent models, and the combined-phytochemical work in SENCAR mice reports on skin tumorigenesis with D-glucarate among the agents Kowalczyk 2013. The chemoprevention rationale was developed explicitly around detoxifying carcinogens before they can act Hanausek 2003.

In humans the pharmacology was characterized decades ago and the clinical trials never followed. Metabolism, uptake and excretion of a D-glucaric acid salt were described alongside its proposed use in cancer prevention Walaszek 1997. That is a pharmacokinetic and mechanistic paper, and it remains close to the state of the human evidence.

The obstacle to transfer is dose, and the arithmetic is unfavorable. The rodent chemoprevention doses correspond, on a body-weight basis, to human intakes far above the 500 to 1,500 mg a day that products supply. Rodent studies also fed the salt continuously in the diet rather than as one or two capsules, which matters for a compound whose active form is generated slowly in the gut Walaszek 1997.

And there is no trial with a human endpoint of any kind. No randomized study has reported cancer incidence, hormone-sensitive disease outcomes, or even a validated hormone measurement after calcium D-glucarate supplementation. The modern work on it is computational rather than clinical Ayyadurai 2023.

The adjacent product shows what the trial would look like. When somebody wanted to test an estrogen-metabolism claim properly, they gave a defined compound to postmenopausal women on a transdermal estradiol patch and measured estradiol and its metabolites Newman 2025. That design exists, it is affordable, and nobody has run it for this molecule.

Calcium D-Glucarate — which form, and does it matter

The salt, the free acid and the lactone are three materials. Calcium D-glucarate is the stable salt on the shelf; D-glucaric acid is the free acid; D-glucaro-1,4-lactone is the actual inhibitor and is chemically unstable in aqueous solution, which is exactly why the salt is sold instead Walaszek 1997.

The calcium is not decorative and is not negligible. Calcium D-glucarate is roughly 10 to 12 percent calcium by weight, so 1,500 mg a day supplies about 150 to 180 mg of elemental calcium. That is small against a daily requirement and not zero against a supplement stack that already contains calcium.

The exposure numbers are the weakest part of the case. Oral D-glucarate is absorbed and largely excreted unchanged, and the fraction converted to the active lactone in vivo is small and pH-dependent; plasma D-glucaro-1,4-lactone concentrations after an oral salt dose are low and short-lived, with renal clearance of the acid dominating Walaszek 1997. There is no cytochrome step and no hepatic first-pass barrier — the compound is not metabolized so much as chemically interconverted and excreted.

Which produces an awkward mismatch with the claimed site of action. The target enzyme is bacterial and lives in the colon; the lactone is generated in the stomach and small intestine and is unstable. How much inhibitory lactone actually reaches colonic beta-glucuronidase after an oral capsule has never been measured in a person, and it is the single number this product's case depends on.

The dosing convention follows from instability rather than from a trial. Products recommend divided doses, typically 500 mg two or three times daily, on the reasoning that continuous low-level generation beats a single bolus. That is a chemically sensible inference and it has not been tested against once-daily dosing for any endpoint Ayyadurai 2023.

What would have to be true, and how you would know it was not

1. Predict that no accessible marker moves, and treat that as the honest starting point. There is no clinical assay for beta-glucuronidase activity, for D-glucaro-1,4-lactone, or for enterohepatic recirculation rate. Predict a standard panel is unchanged at 12 weeks, because nothing on it reports the mechanism Walaszek 1997.

2. Predict the estrogen claim needs a hormone measurement and predict it does not move much. Predict estradiol, sensitive (LC/MS-MS), total estrogens and SHBG (sex hormone-binding globulin) essentially unchanged at 12 weeks on 1,500 mg a day, because reducing one reabsorption route is a small perturbation on a hormone whose production is under feedback control.

3. The prediction that cuts against the product. Predict that no randomized trial reports a clinical or hormonal outcome for calcium D-glucarate, because none exists Hanausek 2003 Ayyadurai 2023. A trial of the kind already run for the adjacent estrogen-metabolism product Newman 2025 would falsify this page's central claim, either way, and would take twelve weeks.

4. Predict a drug interaction before predicting a benefit. Predict that anything cleared by glucuronidation with meaningful enterohepatic recycling shows a changed exposure — hormonal contraceptives, raloxifene and tamoxifen metabolites, mycophenolate, lamotrigine Kemp 2002. That is the more likely detectable effect of this supplement and it is the reverse of how it is marketed.

5. Predict the calcium is the only thing you can verify. Predict serum calcium unchanged and predict the 150 to 180 mg of elemental calcium per day is the one component of this product whose delivery is certain. That is a small, unflattering, checkable fact.

What nobody has tested yet

Nobody has measured colonic beta-glucuronidase activity after a human dose. Fecal beta-glucuronidase can be assayed. Nobody has reported it before and after calcium D-glucarate supplementation in people, which means the first step of the proposed mechanism is unverified in the species it is sold to Walaszek 1997.

The hormone question has never been asked properly. A randomized crossover measuring serum and urinary estrogen metabolites with mass spectrometry would settle the commonest claim on this product Newman 2025, and it has not been attempted.

The chemoprevention hypothesis stalled at rodents thirty years ago. The animal data and the mechanistic rationale are old and coherent Hanausek 2003 Kowalczyk 2013, and no human chemoprevention trial followed. Whether that is because the compound failed quietly or because nobody funded it is not recoverable.

And the microbiome dimension is entirely unexplored. Beta-glucuronidase output varies enormously between people depending on their gut bacteria, which predicts that responders and non-responders would be identifiable by stool assay. No study has looked Ayyadurai 2023.

Calcium D-Glucarate — its own safety story, not its category's

Direct toxicity appears to be very low and the evidence base for that is thin rather than reassuring. Reported effects are mild and gastrointestinal — loose stools, bloating — and there is no established tolerable upper intake level, largely because no adequate human safety study has been performed Walaszek 1997.

The interaction risk is the substantive safety story and it follows directly from the mechanism. A compound that reduces deconjugation in the gut reduces the reabsorption of anything relying on enterohepatic recycling. Hormonal contraceptives are the clearest example, because ethinylestradiol's efficacy depends in part on that loop; reduced exposure means reduced contraceptive reliability, and this is not a theoretical concern Kemp 2002.

The same logic applies to several prescription drugs. Mycophenolate, lamotrigine, raloxifene, irinotecan's active metabolite and morphine glucuronides are all handled by the conjugation-deconjugation cycle. No clinical interaction study exists for calcium D-glucarate with any of them, which makes this an unquantified rather than an absent risk.

The calcium is a small additional consideration. At 1,500 mg a day the product contributes roughly 150 to 180 mg of elemental calcium, which matters only for somebody already near their intake ceiling or with a history of calcium stones.

Who should be careful, and one honest summary. Anyone on a hormonal contraceptive; anyone on a drug cleared by glucuronidation; anyone pregnant or breastfeeding, where there are no data; and anyone taking it for estrogen dominance, which is not a diagnosis and cannot be tested for. This is a compound with a coherent mechanism, thirty-year-old rodent data and no human outcome evidence Ayyadurai 2023. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.

Calcium D-Glucarate safety basics2 points of its own, standing advice

Its own safety story

  • Well tolerated; mild GI upset at higher doses.
  • It works by speeding clearance of things that leave via glucuronidation — which includes many medications, oral contraceptives among them. That is the mechanism, not a side effect, and it applies to drugs you want to keep.

Standing advice: pregnancy and breastfeeding

  • Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.

The same on every page it applies to.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run4 tests in one order, code CAMERON

Calcium D-Glucarate FAQ5 common questions

What is Calcium D-Glucarate?
Inhibits beta-glucuronidase, the gut enzyme that un-conjugates estrogen your liver already packaged for excretion — letting it be reabsorbed instead.
What is the suggested dose of Calcium D-Glucarate?
500–1,500 mg daily. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Calcium D-Glucarate for?
Estrogen clearance protocols, usually alongside DIM.
Which labs show whether Calcium D-Glucarate is doing anything?
Estradiol, Sensitive (LC/MS-MS), Comprehensive Metabolic Panel (CMP), SHBG (Sex Hormone-Binding Globulin), Estrogens, Total. Draw a baseline before you start, then recheck.
Where can I buy Calcium D-Glucarate?
Coach Cam sources Calcium D-Glucarate from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Calcium D-Glucarate is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Calcium D-Glucarate is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Calcium D-Glucarate is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Calcium D-Glucarate in your full stack: what it runs with, and what it cancels out
  • Its place in 3 Protocol Blueprints (Testosterone, Female Hormone, Detox & Liver Support), week by week
  • The retest plan: Estradiol, Sensitive (LC/MS-MS) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool